Publications by authors named "O Saydam"
Objective: We aimed to assess the real-world label adherence of non-vitamin K antagonist oral anticoagulant (NOAC) dosing patterns, including apixaban, edoxaban, and rivaroxaban, in Turkish patients with atrial fibrillation.
Methods: This was an observational, prospective, cross-sectional, multicenter study. Patients with atrial fibrillation (AF) who were prescribed NOACs within the last 4 months were recruited from 34 cardiology clinics in Türkiye.
Article Synopsis
- * Overexpression of OTX2 in Group 3 MB cells increases growth, movement, and polarization, leading to decreased survival in animal models due to the development of brain and spinal cord metastases.
- * OTX2 activates the mTOR gene and its signaling pathway, enhancing cell migration, with a strong correlation found between OTX2 and mTOR expression in human MB samples, suggesting potential therapeutic targets by inhibiting mTORC2.
Background: This study aims to investigate whether the invasive staging of aortopulmonary window lymph nodes could be omitted in the presence of a suspected isolated metastasis in the aortopulmonary window lymph node on positron emission tomography/computed tomography.
Methods: Between January 2010 and January 2016, a total of 67 patients (54 males, 13 females; mean age: 59.9±8.
Glioblastoma is one of the most devastating neoplasms of the central nervous system. This study focused on the development of serum extracellular vesicle (EV)-based glioblastoma tumor marker panels that can be used in a clinic to diagnose glioblastomas and to monitor tumor burden, progression, and regression in response to treatment. RNA sequencing studies were performed using RNA isolated from serum EVs from both patients ( = 85) and control donors ( = 31).
View Article and Find Full Text PDFSurvival impact of unexpected N2 in stage IIIB/N2 non-small cell lung cancer patients.
Asian Cardiovasc Thorac Ann
March 2023
Background: We investigated the effect of unexpected N2 on survival in stage IIIB/N2 cases.
Methods: We retrospectively analyzed 1803 non-small cell lung cancer patients between 2010 and 2016. There were 89 patients (4.